UNSPSC 51422428: Hydrocortisone caproate

This classification denotes an anti-inflammatory agent C27H40O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SAE475O6E4, chemically known as cortisol, 21-hexanoate, but more generally known as hydrocortisone caproate, which bears US NIH Compound Identifier 107423. Most nations, for tariff and trade purposes, schedule hydrocortisone caproate under HS 29372100 and SITC 54153. As of Q4 2014, HYDROCORTISONE CAPROATE remains US FDA's Preferred Term for this commodity.

SMILES: CCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O.

UNSPSC 51422428 Hydrocortisone caproate is a Commodity code intended to classify a specific pharmaceutical product, but the recent state and local opportunities tagged under it show a material mismatch with the code's nominal scope. The Seminole County, Florida opportunity solicits Naloxone and Safe Drug Deactivation Systems—neither of which is hydrocortisone caproate—while the Texas Health and Human Services Commission RFI addresses direct-to-manufacturer prescription fulfillment infrastructure and pharmacy benefit program design, also unrelated to the code's stated product. State and local procurement offices appear to be using this code as a catch-all for pharmacy and pharmaceutical procurement rather than as a classifier for this specific corticosteroid product. The issuing bodies sourcing under the code include county health departments and state health and human services agencies pursuing supply and program-management initiatives.

Opportunities show activity in Florida and Texas, with the Seminole County IFB (IFB60459723LAS, response deadline July 26, 2023) representing a recurring annual procurement for naloxone and drug deactivation systems with quarterly deliveries, and the Texas HHS RFI (HHS0017013, posted April 3, 2026) seeking vendor input on direct pharmaceutical contracting models outside traditional pharmacy benefit manager and group purchasing organization channels. The mismatch between the code's definition and the actual procurement scope suggests that firms pursuing contracts under this Commodity designation should verify the specific pharmaceutical products or pharmacy services actually required in any given solicitation rather than rely on the code name alone.